NEUROD1 (Ab-274) Antibody

What is NEUROD1 and why is it important in research?

NEUROD1 (Neuronal Differentiation 1) is a transcription factor that plays a crucial role in maintaining the mature phenotype of pancreatic β cells and is essential for proper neuronal differentiation. It functions as part of a regulatory network critical for endocrine lineage commitment and differentiation. Disruption of Neurod1 during pancreatic development causes severe neonatal diabetes, highlighting its significance in endocrine cell development . NEUROD1 has also demonstrated pioneering activity in neuron differentiation, where it both activates cell type-specific genes and represses genes associated with alternative non-neuronal lineages . The protein is approximately 40 kDa in size and contains a basic helix-loop-helix domain that facilitates DNA binding and transcriptional regulation .

What are the primary applications for NEUROD1 antibodies in research?

NEUROD1 antibodies are primarily used in Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF), Immunocytochemistry (ICC), and Enzyme-Linked Immunosorbent Assay (ELISA) . These antibodies allow researchers to detect and quantify NEUROD1 expression in various experimental contexts, including:

• Studying pancreatic endocrine cell differentiation and development

• Investigating β cell maturation and function

• Examining neuronal differentiation processes

• Analyzing NEUROD1's role in transcriptional regulation

• Assessing alterations in NEUROD1 expression in disease models of diabetes or neurological disorders

How should researchers select the appropriate NEUROD1 antibody for their experiment?

Selection of the appropriate NEUROD1 antibody should be based on several factors:

• Target epitope specificity: Determine if your research requires targeting specific phosphorylation sites (like Ser272) or particular amino acid regions of NEUROD1 .

• Host species and clonality: Consider whether a rabbit polyclonal (offering broader epitope recognition) or mouse monoclonal (providing higher specificity) better suits your experimental needs .

• Species reactivity: Verify that the antibody reacts with your species of interest (human, mouse, rat, etc.) .

• Application compatibility: Ensure the antibody is validated for your specific application (WB, IHC, IF, etc.) .

• Conjugation requirements: Determine if you need an unconjugated antibody or one conjugated to a reporter molecule, depending on your detection system .

The NEUROD1 (Ab-274) antibody and other antibodies targeting the Ser272 region are particularly useful for studying the phosphorylation state of NEUROD1, which may influence its activity in transcriptional regulation .

What are the optimal protocols for using NEUROD1 (Ab-274) antibody in Western blotting?

When using NEUROD1 antibodies for Western blotting, researchers should follow these methodological guidelines:

• Sample preparation: Extract proteins from cells or tissues using a lysis buffer containing protease and phosphatase inhibitors to preserve NEUROD1's phosphorylation state at Ser272.

• Protein loading: Load 20-40 μg of total protein per lane, as NEUROD1 is a transcription factor with potentially lower abundance.

• Resolution: Use a 10-12% SDS-PAGE gel to achieve optimal separation of the ~40 kDa NEUROD1 protein .

• Transfer: Transfer proteins to a PVDF membrane, which tends to have better protein retention for transcription factors.

• Blocking: Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute NEUROD1 antibody (typically 1:1000-1:2000) in blocking buffer and incubate overnight at 4°C.

• Detection: Use appropriate secondary antibodies and develop using chemiluminescence or fluorescence-based detection systems.

For phospho-specific detection, it's crucial to maintain phosphatase inhibitors throughout the procedure and consider using phospho-specific blocking reagents .

How should NEUROD1 antibodies be used in immunohistochemistry and immunofluorescence applications?

For optimal results in IHC and IF applications with NEUROD1 antibodies:

• Fixation: Use 4% paraformaldehyde for tissues or cells, as it preserves epitope structure while maintaining tissue morphology.

• Antigen retrieval: Perform heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) for optimal NEUROD1 detection.

• Blocking: Block with 5-10% normal serum from the same species as the secondary antibody, plus 0.1-0.3% Triton X-100 for membrane permeabilization.

• Primary antibody incubation: Dilute NEUROD1 antibody (typically 1:100-1:500 for IHC/IF) and incubate overnight at 4°C.

• Detection: For IF, use fluorophore-conjugated secondary antibodies; for IHC, use an appropriate detection system compatible with your primary antibody species.

• Controls: Always include positive controls (tissues known to express NEUROD1, such as pancreatic islets) and negative controls (primary antibody omission) .

When studying pancreatic tissues, co-staining with insulin (β cells) or glucagon (α cells) markers can provide valuable contextual information about NEUROD1 expression patterns .

What considerations are important when using NEUROD1 antibodies in different species?

When working with NEUROD1 antibodies across different species, researchers should consider:

• Verified cross-reactivity: Confirm that the NEUROD1 antibody has been validated for your species of interest. Some antibodies, like certain rabbit polyclonal antibodies, have demonstrated reactivity with human, mouse, and rat NEUROD1 .

• Sequence homology: NEUROD1 is highly conserved across mammals, with the region around Ser272 showing particular conservation. Antibodies targeting this region may work across multiple species, but validation is essential.

• Antibody concentration adjustment: Different species may require different antibody concentrations for optimal results. Always perform a dilution series when using an antibody in a new species.

• Background considerations: Non-specific binding patterns can vary between species. Species-specific blocking reagents (such as serum from the same species as the tissue) can help reduce background.

• Validation methods: When using NEUROD1 antibodies in a new species, validate specificity through multiple methods (western blot, peptide competition, knockout controls) .

How can NEUROD1 (Ab-274) antibody be used to study pancreatic β cell development and differentiation?

NEUROD1 antibodies can be utilized to investigate pancreatic β cell development through several advanced approaches:

• Temporal expression analysis: Track NEUROD1 expression during different developmental stages using immunostaining of pancreatic tissues, revealing its role in endocrine cell differentiation.

• Co-localization studies: Perform dual immunofluorescence with markers of endocrine progenitors (Ngn3), mature β cells (Insulin), or other endocrine cell types (Glucagon, Somatostatin) to understand the progression of differentiation.

• Phosphorylation-specific detection: Use phospho-specific antibodies targeting Ser272 to monitor NEUROD1 activation status during differentiation, as phosphorylation may regulate its activity.

• ChIP analysis: Combine NEUROD1 antibodies with chromatin immunoprecipitation to identify direct target genes during β cell differentiation.

• Single-cell analysis: Apply NEUROD1 antibodies in single-cell proteomics approaches to identify heterogeneity in endocrine progenitor populations .

Research has shown that NEUROD1 deficiency leads to significant reductions in insulin-producing β cells and glucagon-producing α cells, with reductions in cell proliferation observed as early as E17.5 during mouse development .

What is the role of NEUROD1 phosphorylation at Ser272 and how can phospho-specific antibodies be used to study this modification?

NEUROD1 phosphorylation at Ser272 occurs within a proline-rich region (P-L-S-P-P) and is believed to regulate its transcriptional activity and protein stability. Phospho-specific antibodies against this site can be employed to:

• Monitor activation status: Track when and where NEUROD1 becomes phosphorylated during differentiation or in response to signaling events.

• Identify regulatory kinases: Use kinase inhibitors in combination with phospho-specific detection to identify the kinases responsible for Ser272 phosphorylation.

• Study signaling pathways: Investigate how different stimuli (glucose levels, growth factors, stress conditions) affect NEUROD1 phosphorylation status.

• Analyze structure-function relationships: Compare the DNA binding activity and protein interactions of phosphorylated versus non-phosphorylated NEUROD1 .

The phospho-specific NEUROD1 (Ab-274) antibody can be particularly valuable when studying how phosphorylation affects NEUROD1's ability to regulate genes such as Ins1, which has been shown to be directly dependent on NEUROD1 activity .

How can NEUROD1 antibodies be used in the context of studying diabetes pathogenesis?

NEUROD1 antibodies can be instrumental in diabetes research through several sophisticated approaches:

• Islet architecture analysis: Examine changes in NEUROD1 expression and localization in islets from diabetic models compared to healthy controls.

• β cell maturation assessment: Evaluate NEUROD1's role in maintaining mature β cell identity, which is often compromised in diabetes.

• Transcriptional network analysis: Combine NEUROD1 immunoprecipitation with mass spectrometry to identify protein interaction partners in normal versus diabetic conditions.

• Epigenetic regulation: Use NEUROD1 antibodies for CUT&Tag-seq approaches to examine changes in chromatin binding patterns in diabetic models.

• Therapeutic interventions: Monitor NEUROD1 expression and activity following experimental treatments aimed at preserving or restoring β cell function .

Research has demonstrated that Neurod1 deficiency alters the H3K27me3 histone modification pattern in promoter regions of differentially expressed genes, resulting in gene regulatory network changes that compromise endocrine cell potential, differentiation, and functional properties .

What are common technical issues when using NEUROD1 antibodies and how can they be resolved?

Researchers may encounter several challenges when using NEUROD1 antibodies:

• Weak or absent signal:

  • Increase antibody concentration or incubation time

  • Optimize antigen retrieval methods (try different buffers or heating times)

  • Use signal enhancement systems (HRP polymers, amplification kits)

  • Ensure samples are properly processed to preserve the epitope

• High background:

  • Increase blocking time or concentration

  • Reduce primary and secondary antibody concentrations

  • Add 0.1-0.3% Triton X-100 to reduce non-specific binding

  • Use more stringent washing steps (increase number or duration)

• Non-specific bands in Western blot:

  • Increase blocking concentration

  • Optimize antibody dilution

  • Include additional washing steps

  • Consider using gradient gels for better protein separation

• Inconsistent results between experiments:

  • Standardize all protocols and reagents

  • Prepare fresh working solutions for each experiment

  • Implement positive and negative controls for every experiment

  • Consider lot-to-lot variations in antibodies

How can researchers validate the specificity of NEUROD1 antibodies in their experimental systems?

Validating antibody specificity is crucial for reliable results. For NEUROD1 antibodies, consider these validation approaches:

• Positive and negative tissue controls: Test the antibody on tissues known to express (pancreatic islets, developing neurons) or lack (mature liver) NEUROD1.

• siRNA or CRISPR knockdown: Verify decreased signal after NEUROD1 knockdown or knockout.

• Overexpression systems: Confirm increased signal in cells overexpressing NEUROD1.

• Peptide competition assay: Pre-incubate the antibody with the immunizing peptide before application to samples. This should eliminate specific binding.

• Multiple antibody comparison: Test several NEUROD1 antibodies targeting different epitopes and compare staining patterns.

• Western blot correlation: Confirm that immunostaining intensity correlates with protein levels detected by Western blot.

• Phosphatase treatment: For phospho-specific antibodies, treat samples with phosphatase and confirm loss of signal .

What controls should be included when using NEUROD1 antibodies in experimental designs?

A robust experimental design with NEUROD1 antibodies should include:

• Positive controls:

  • Known NEUROD1-expressing tissues (pancreatic islets, developing brain)

  • Cell lines with confirmed NEUROD1 expression (βTC-6, MIN6)

  • Recombinant NEUROD1 protein (for Western blot)

• Negative controls:

  • Primary antibody omission

  • Isotype control antibody

  • Tissues or cells known not to express NEUROD1

  • NEUROD1 knockout or knockdown samples (if available)

• Specificity controls:

  • Peptide competition assay

  • Multiple antibodies against different NEUROD1 epitopes

  • Phosphatase treatment (for phospho-specific antibodies)

• Technical controls:

  • Loading controls for Western blot (β-actin, GAPDH)

  • Nuclear counterstain for localization studies (DAPI)

  • Co-staining with established markers (insulin for β cells)

How should quantitative data from NEUROD1 antibody experiments be analyzed and interpreted?

Quantitative analysis of NEUROD1 expression requires careful consideration:

• Western blot quantification:

  • Normalize NEUROD1 signal to appropriate loading controls (preferably nuclear proteins for transcription factors)

  • Use linear range of detection for accurate quantification

  • Apply statistical analysis appropriate for your experimental design (t-test, ANOVA)

  • Present data as fold-change relative to control conditions

• Immunohistochemistry/Immunofluorescence quantification:

  • Define clear criteria for positive cells (intensity threshold, subcellular localization)

  • Count sufficient number of cells/fields (minimum 100-300 cells per condition)

  • Consider automated image analysis software for unbiased quantification

  • Report percentage of positive cells and/or mean fluorescence intensity

• Correlation with functional outcomes:

  • Relate NEUROD1 expression changes to functional parameters (insulin secretion, gene expression)

  • Consider temporal dynamics of NEUROD1 expression and activity

  • Analyze subcellular localization (nuclear vs. cytoplasmic) as indicator of activity

Studies have shown that NEUROD1 deficiency leads to downregulation of endocrine differentiation transcription factors and upregulation of non-endocrine genes, highlighting the importance of analyzing both NEUROD1 expression and its downstream targets .

What approaches can be used to study NEUROD1's interaction with the chromatin landscape?

Advanced techniques to investigate NEUROD1's role in chromatin regulation include:

• ChIP-seq/CUT&Tag-seq:

  • Use NEUROD1 antibodies to immunoprecipitate chromatin and identify genome-wide binding sites

  • Compare binding profiles in different cell states or disease models

  • Integrate with transcriptomic data to identify direct target genes

• Co-immunoprecipitation with chromatin modifiers:

  • Investigate NEUROD1's interaction with histone-modifying enzymes

  • Examine how these interactions change during differentiation or disease

• Histone modification analysis:

  • Correlate NEUROD1 binding with activating (H3K4me3, H3K27ac) or repressive (H3K27me3) histone marks

  • Study how NEUROD1 deficiency affects the epigenetic landscape

• Accessibility studies:

  • Combine NEUROD1 binding data with ATAC-seq to examine chromatin accessibility

  • Investigate NEUROD1's role as a pioneer factor in opening chromatin regions

Research has demonstrated that Neurod1 deficiency alters the H3K27me3 histone modification pattern in promoter regions of differentially expressed genes, suggesting a mechanistic link between NEUROD1 activity and epigenetic regulation .

How can NEUROD1 antibodies be integrated with single-cell analysis techniques?

Integrating NEUROD1 antibodies with single-cell technologies offers powerful insights:

• Mass cytometry (CyTOF):

  • Combine NEUROD1 antibodies with metal isotope tags for multiparameter single-cell analysis

  • Profile heterogeneity in NEUROD1 expression alongside other transcription factors and cell type markers

• Single-cell Western blotting:

  • Analyze NEUROD1 protein levels in individual cells to capture population heterogeneity

  • Correlate with functional parameters at the single-cell level

• Imaging mass cytometry:

  • Apply metal-tagged NEUROD1 antibodies to tissue sections for spatial analysis

  • Preserve tissue architecture while obtaining single-cell resolution data

• Spatial transcriptomics integration:

  • Correlate NEUROD1 protein expression with spatial gene expression patterns

  • Map the relationship between NEUROD1 activity and tissue microenvironments

• Computational analysis:

  • Apply clustering algorithms to identify distinct cell populations based on NEUROD1 and other markers

  • Construct pseudotime trajectories to map differentiation pathways influenced by NEUROD1

How are NEUROD1 antibodies being used in regenerative medicine research?

NEUROD1 antibodies are contributing to regenerative medicine advancements through:

• Stem cell differentiation monitoring:

  • Track NEUROD1 expression during directed differentiation of stem cells to β-like cells

  • Identify optimal time points for transplantation based on NEUROD1 expression patterns

  • Assess maturation status of differentiated cells

• Transdifferentiation studies:

  • Monitor NEUROD1 expression during conversion of other cell types to β cells

  • Evaluate NEUROD1's role as a master regulator in reprogramming processes

• In vivo regeneration assessment:

  • Analyze endogenous NEUROD1 expression after regenerative therapies

  • Correlate NEUROD1 levels with functional recovery metrics

• Engineered tissue quality control:

  • Use NEUROD1 as a marker for properly differentiated endocrine cells in bioengineered islets

  • Quantify the proportion of mature, NEUROD1-expressing cells in transplantable constructs

What is the significance of NEUROD1 in neuronal differentiation and how can antibodies help study this process?

NEUROD1 plays a crucial role in neuronal differentiation, which can be studied using antibodies through:

• Developmental neurobiology:

  • Track NEUROD1 expression during neural development

  • Correlate with markers of neuronal maturation and subtype specification

• Neural stem cell research:

  • Monitor NEUROD1 expression during neural stem cell differentiation

  • Analyze the relationship between NEUROD1 and cell fate decisions

• Neuronal reprogramming:

  • Assess NEUROD1's role as a pioneering factor in neuronal transdifferentiation

  • Examine changes in chromatin structure during NEUROD1-mediated reprogramming

• Neurological disorders:

  • Investigate alterations in NEUROD1 expression in neurodevelopmental disorders

  • Explore NEUROD1's potential role in neurodegeneration or neural repair

Research has shown that NEUROD1 exhibits pioneering activity in neuron differentiation, both activating cell type-specific genes and repressing genes associated with alternative non-neuronal lineages, making it indispensable for neuronal differentiation, survival, and reprogramming .

How can researchers combine NEUROD1 antibodies with other technological approaches for comprehensive phenotyping?

Integrative approaches using NEUROD1 antibodies include:

• Multi-modal phenotyping:

  • Combine NEUROD1 immunostaining with functional assays (calcium imaging, insulin secretion)

  • Correlate NEUROD1 expression with electrophysiological properties of cells

• Lineage tracing integration:

  • Use NEUROD1 antibodies in conjunction with genetic lineage tracing to track cell fate decisions

  • Identify the progeny of NEUROD1-expressing progenitors

• Live cell imaging:

  • Apply cell-permeable NEUROD1 antibody fragments for real-time monitoring of expression

  • Track dynamics of NEUROD1 nuclear translocation during differentiation

• Omics integration:

  • Correlate NEUROD1 protein levels with transcriptomic, proteomic, or metabolomic data

  • Construct integrated regulatory networks centered on NEUROD1 activity

• Computational modeling:

  • Use quantitative NEUROD1 expression data to inform mathematical models of cell differentiation

  • Predict cellular behaviors based on NEUROD1 levels and modification states

By combining these complementary approaches, researchers can develop a more nuanced understanding of NEUROD1's multifaceted roles in development, differentiation, and disease.